Local Institution

Cambridge CB2 2QQ

0 studies enrolling now · 5 studies all time

What they study most

Carcinoma, Non-small Cell Lung, Leukemia, Pediatric, Melanoma, Rheumatoid Arthritis, Skin Cancer

Studies at this site

• Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation — Stopped early
• Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia — Completed
• An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma — Completed
• Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants — Withdrawn before enrolling
• Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis — Completed